NPJ breast cancer
Adherence to oral endocrine therapy by menopausal status: post hoc insights from a remote monitoring randomized trial.
Ilana Graetz, Xin Hu, Rebecca A Krukowski, Janeane N Anderson, Edward Stepanski, Gregory Vidal, Teresa M Waters, Lee S Schwartzberg
Published: 202610.1038/s41523-026-00900-9
Abstract
Oral adjuvant endocrine therapy (AET) improves survival in hormone receptor-positive breast cancer, but younger, premenopausal women often struggle with adherence. In a post hoc analysis of a randomized trial (N = 304), app-based remote symptom monit…
Preview only. Read the full abstract at the source